» Articles » PMID: 29426936

Genetic Alterations Driving Metastatic Colony Formation Are Acquired Outside of the Primary Tumour in Melanoma

Abstract

Mouse models indicate that metastatic dissemination occurs extremely early; however, the timing in human cancers is unknown. We therefore determined the time point of metastatic seeding relative to tumour thickness and genomic alterations in melanoma. Here, we find that lymphatic dissemination occurs shortly after dermal invasion of the primary lesion at a median thickness of ~0.5 mm and that typical driver changes, including BRAF mutation and gained or lost regions comprising genes like MET or CDKNA2, are acquired within the lymph node at the time of colony formation. These changes define a colonisation signature that was linked to xenograft formation in immunodeficient mice and death from melanoma. Thus, melanoma cells leave primary tumours early and evolve at different sites in parallel. We propose a model of metastatic melanoma dormancy, evolution and colonisation that will inform direct monitoring of adjuvant therapy targets.

Citing Articles

Molecular Underpinnings of Brain Metastases.

Jacome M, Wu Q, Chen J, Mohamed Z, Mokhtari S, Pina Y Int J Mol Sci. 2025; 26(5).

PMID: 40076927 PMC: 11900073. DOI: 10.3390/ijms26052307.


Preclinical pharmaco-toxicological screening of biomimetic melanin-like nanoparticles as a potential therapeutic strategy for cutaneous melanoma.

Marcovici I, Chioibas R, Zupko I, Pinzaru I, Moaca A, Ledeti A Front Pharmacol. 2025; 16:1487854.

PMID: 39981176 PMC: 11839674. DOI: 10.3389/fphar.2025.1487854.


A Melanoma Brain Metastasis CTC Signature and CTC:B-cell Clusters Associate with Secondary Liver Metastasis: A Melanoma Brain-Liver Metastasis Axis.

Bowley T, Ortiz M, Lagutina I, Steinkamp M, Fahy B, Tawfik B Cancer Res Commun. 2025; 5(2):295-308.

PMID: 39831781 PMC: 11816052. DOI: 10.1158/2767-9764.CRC-24-0498.


Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis.

Dalla E, Papanicolaou M, Park M, Barth N, Hou R, Segura-Villalobos D Cell. 2024; 187(23):6631-6648.e20.

PMID: 39378878 PMC: 11568918. DOI: 10.1016/j.cell.2024.09.016.


Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma.

Gulati S, Barata P, Elliott A, Bilen M, Burgess E, Choueiri T J Clin Invest. 2024; 134(14).

PMID: 39007269 PMC: 11245151. DOI: 10.1172/JCI176230.


References
1.
Hutchinson J, Jin J, Cardiff R, Woodgett J, Muller W . Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res. 2004; 64(9):3171-8. DOI: 10.1158/0008-5472.can-03-3465. View

2.
Schwarz R, Trinh A, Sipos B, Brenton J, Goldman N, Markowetz F . Phylogenetic quantification of intra-tumour heterogeneity. PLoS Comput Biol. 2014; 10(4):e1003535. PMC: 3990475. DOI: 10.1371/journal.pcbi.1003535. View

3.
Verlinden I, van den Hurk K, Clarijs R, Willig A, Stallinga C, Roemen G . BRAFV600E immunopositive melanomas show low frequency of heterogeneity and association with epithelioid tumor cells: a STROBE-compliant article. Medicine (Baltimore). 2014; 93(28):e285. PMC: 4603111. DOI: 10.1097/MD.0000000000000285. View

4.
Yancovitz M, Litterman A, Yoon J, Ng E, Shapiro R, Berman R . Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma. PLoS One. 2012; 7(1):e29336. PMC: 3250426. DOI: 10.1371/journal.pone.0029336. View

5.
Husemann Y, Geigl J, Schubert F, Musiani P, Meyer M, Burghart E . Systemic spread is an early step in breast cancer. Cancer Cell. 2008; 13(1):58-68. DOI: 10.1016/j.ccr.2007.12.003. View